NCT03647826 is a NA clinical trial of Mind Power Intervention in Mental Depression, sponsored by Norwegian Institute of Public Health.

Who is sponsoring NCT03647826?

NCT03647826 is sponsored by Norwegian Institute of Public Health.

What drugs are being tested in NCT03647826?

Interventions in NCT03647826: Mind Power Intervention.

What condition does NCT03647826 study?

NCT03647826 studies Mental Depression, Mental Stress, Mental Health Wellness 1.

Is NCT03647826 still recruiting?

NCT03647826 is currently completed. Last updated 23 March 2023.

Last reviewed 2023-03-23 · How we verify

NCT03647826

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mind Power - A CBT Based Program for Adolescents

Completed NA Last updated 23 March 2023

What this trial tests

NA trial testing Mind Power Intervention in Mental Depression in 1,673 participants. Completed in 26 November 2019.

Timeline

1 September 2018

Primary endpoint
26 November 2019

26 November 2019

Quick facts

Lead sponsor	Norwegian Institute of Public Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	prevention
Enrollment	1,673
Start date	1 September 2018
Primary completion	26 November 2019
Estimated completion	26 November 2019
Sites	1 location across Norway

Drugs / interventions tested

Mind Power Intervention

Conditions studied

Mental Depression — all drugs for Mental Depression →
Mental Stress — all drugs for Mental Stress →
Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →

Sponsor

Norwegian Institute of Public Health

Who can join

Adults 15 to 17, any sex, with Mental Depression or Mental Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to strengthen school achievement and positive mental health, and to prevent and reduce school dropout and mental distress among high school students. The researchers will scale up techniques that have already been proven highly effective in preventing common mental disorders (depression, anxiety) in high risk groups (indicated and selective prevention). The researchers will disseminate these techniques to entire first year classes of high school students irrespective of risk factors (universal prevention). The study will report whether universal delivery in school of "Mind Power" - a Cognitive Behaviour Therapy (CBT) based programme - will strengthen school grades, self-efficacy, self-esteem, self-regulation, mental perceptions and well-being, and prevent and reduce school dropout, and symptoms of anxiety and depression. In addition the researchers will analyse whether such universal delivery prevents more mental distress, and is more cost-effective than when it is delivered only to those at high risk for school failure, dropout, or mental distress.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of a school-based intervention on levels of anxiety and depression: a cluster-randomized controlled trial of the MindPower program in ten high schools in Norway.
Sælid GA, Czajkowski NO, Aarø LE, Andersen JR, et al · · 2022 · cited 2× · PMID 35074007 · DOI 10.1186/s40359-022-00721-y
Challenges in establishing positive mental health effects of a school-based intervention: a cluster-randomized controlled trial of a life skill program in ten public high schools in Norway
Sælid GA, Czajkowski NO, Aarø LE, Idsøe T, et al · · 2021 · DOI 10.21203/rs.3.rs-878704/v1
Effects of a School-Based Intervention On Levels of Anxiety and Depression: A Cluster-Randomized Controlled Trial of The MindPower Program in Ten High Schools in Norway
Sælid GA, Czajkowski N, Aarø LE, Andersen JR, et al · · 2021 · DOI 10.21203/rs.3.rs-737298/v1

Verify or expand the search:

Other recruiting trials for Mental Depression

Currently open trials in the same condition.

NCT05946382 — A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress. · NA · active not recruiting

Other Norwegian Institute of Public Health trials

Trials by the same sponsor.

NCT07442318 — Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia · NA · not yet recruiting
NCT07135115 — Targeting Lifestyle to Improve Colorectal Cancer Screening · NA · not yet recruiting
NCT07355569 — The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway · NA · completed
NCT06324409 — ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening · NA · completed
NCT06374316 — Air Purifiers in Classrooms for Infection Control - a Pilot Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03647826 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian Institute of Public Health
Last refreshed: 23 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03647826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing